Sars-covi-2. so you can do an indication for these antibodies that are twofold. in this regard clinical trials have demonstrated that early treatment with monoclonal antibodies can reduce the risk of covid-19 hospitalization or death by 70 to 85%. it is important to emphasize that this must be done early in infections and not wait, of course, until a person is sick enough to be hospitalized. that s when you get the best effect. we want people out there including physicians as well as potential patients to realize the advantage of this very effective way of treating early